戻る Agenda
Avoiding Rejection on your "First Date" with EMA Policy 0070
Session Chair(s)
Jo Anne-Marie Blyskal, MS
Head of Global Regulatory Medical Writing and Data Disclosure
Teva Pharmaceuticals, United States
This interactive session is an opportunity for participants to share and compare cross-industry experience with the first marketing authorization submissions made public under EMA Policy 0070, and to learn best practices for working with the Agency.